Quinazoline derivatives as metabolically inert antifolate compounds

Details for Australian Patent Application No. 2011202657 (hide)

Owner Chelsea Therapeutics, Inc.

Inventors Pedder, Simon; Roberts, Michael J.

Agent Spruson & Ferguson

Pub. Number AU-A-2011202657

Parent 2005282241

Filing date 3 June 2011

Wipo publication date 23 June 2011

International Classifications

C07D 239/95 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

23 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202657

23 June 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202658-Method for increasing and regulating light emission from a chemiluminescent reaction

2011202656-Method and apparatus to facilitate wireline transmission of an encrypted rolling code